ASX - By Stock
|
PAA |
Re:
Ann: AGM Date & Director Nominations Closing Date for AGM
|
|
NZ Trader
|
17 |
4.4K |
11 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
17
|
4.4K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
36
|
7.8K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
831 |
330K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
831
|
330K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
117
|
30K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Date & Director Nominations Closing Date for AGM
|
|
NZ Trader
|
17 |
4.4K |
4 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
17
|
4.4K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
978
|
265K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
831 |
330K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
831
|
330K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
978
|
265K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
68
|
15K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
36
|
7.8K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
21
|
5.8K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
41 |
9.5K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
41
|
9.5K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
12 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
21
|
5.8K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
21 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
21
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
21
|
5.8K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
41 |
9.5K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
41
|
9.5K
|
2
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
5.5K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
22
|
5.5K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
41 |
9.5K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
41
|
9.5K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
19 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
19
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Further Significant Improvement in Rett Syndrome Patients
|
|
NZ Trader
|
15 |
3.6K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
15
|
3.6K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
41 |
9.5K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
41
|
9.5K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
41 |
9.5K |
4 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
41
|
9.5K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
41 |
9.5K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
41
|
9.5K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
17 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
17
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
41 |
9.5K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
41
|
9.5K
|
6
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
5.5K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
22
|
5.5K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
12 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
8 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
10
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
9 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
21
|
5.8K
|
9
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
5.5K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
22
|
5.5K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Further Significant Improvement in Rett Syndrome Patients
|
|
NZ Trader
|
15 |
3.6K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
15
|
3.6K
|
3
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
28 |
9.6K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
28
|
9.6K
|
0
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
28 |
9.6K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
28
|
9.6K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Further Significant Improvement in Rett Syndrome Patients
|
|
NZ Trader
|
15 |
3.6K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
15
|
3.6K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
73 |
15K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
73
|
15K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
31 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
31
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
NZ Trader
|
157 |
46K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
157
|
46K
|
5
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
28 |
9.6K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
28
|
9.6K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
NZ Trader
|
157 |
46K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
157
|
46K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
36
|
7.8K
|
10
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
7.8K
|
8
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
7.8K
|
8
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
3 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
7.8K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
7.8K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
7.8K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
7.8K
|
8
|
|